What's new

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised

May 28, 2025 - 17:35
 0
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Efficib, sitagliptin,m...

Next Article

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Da...

Related Posts

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Annex to 27-30 January 2025 CHMP Minutes

May 28, 2025  0

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0